Viridian Therapeutics, Inc. (VRDN)
Nasdaq: VRDN · Pharmaceutical Preparations · Waltham, MA · filing with the SEC since 2013
Who owns Viridian Therapeutics, Inc.
As filed with the SECHolders of 5% or more
7
Fairmount Funds Management LLC holds 14% of Common Stock, $0.01 par value per share, as its SCHEDULE 13D/A filed May 13, 2026 says.
Directors and officers
14
report now, of 44 people on the record since 2014. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 7 named at left.
Holders of 5% or moreshare of the class, as filed
Fairmount Funds Management LLC
SCHEDULE 13D/A · filed May 13, 2026 · Common Stock, $0.01 par value per share · 15.1% in Oct 27, 2025
Bellevue Group AG
SCHEDULE 13G · filed May 15, 2026 · Common Stock
Paradigm BioCapital Advisors LP
SCHEDULE 13G/A · filed Aug 14, 2026 · Common Stock, $0.01 par value per share · 5.1% in Jun 26, 2026
Kynam Capital Management, LP
SCHEDULE 13G/A · filed Aug 14, 2026 · Common Stock, $0.01 par value · 1.54% in Feb 17, 2026
State Street Corporation
SCHEDULE 13G · filed Aug 7, 2026 · COMMON STOCK
T. Rowe Price Associates, Inc.
SCHEDULE 13G · filed Aug 14, 2026 · COMMON STOCK
Point72 Asset Management, L.P.
SCHEDULE 13G · filed Aug 20, 2026 · Common Stock, par value $0.01 per share
Venrock Healthcare Capital Partners III, L.P.
SCHEDULE 13G/A · filed Feb 14, 2025 · Common Stock, $0.01 par value per share · reported falling below 5%
Commodore Capital LP
SCHEDULE 13G/A · filed Nov 14, 2025 · Common Stock, $0.01 par value · reported falling below 5%, from 5.3% in Apr 11, 2025
Deep Track Capital, LP
SCHEDULE 13G/A · filed Aug 14, 2026 · Common Stock, $0.01 par value · reported falling below 5%, from 5.3% in May 8, 2026
The Vanguard Group
SCHEDULE 13G/A · filed Mar 27, 2026 · Common Stock · reported falling below 5%
What VRDN reports owning in othersstakes of 5% or more, and other ties
3 subsidiaries in 3 countries, from the list filed with the 10-K filed Feb 26, 2026.
Insider tradesForm 4
3sales
2purchases
0sales on a scheduled plan
1people selling
$400,000sold, in dollars
$30.0Mbought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window3 of 57 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Tousignant Jennifer | Chief Legal Officer | 3 | $400,000 | 0 | 0 | $0 |
| Fairmount Healthcare Fund II Gp LLC | director | 0 | $0 | 0 | 1 | $10.0M |
| Fairmount Healthcare Fund II L.P. | director | 0 | $0 | 0 | 1 | $20.0M |